Humanoid robotics and physical AI sector: JPMorgan stays constructive on humanoid robotics long term but favors Leader Drive and Orbbec as deployment and platform economics become decisive.

Overview

JPMorgan reassesses China’s humanoid-robot supply chain as the industry shifts from demonstrations and hardware scarcity toward commercial deployment, repeatable demand and platform economics. It remains positive on the long-run sector opportunity but favors Leader Drive and Orbbec over OEMs such as UBTech, Unitree and Estun.

Core views

JPMorgan argues that physical AI and humanoid robotics remain a major multi-year automation opportunity, supported by advances in mechatronics, embodied AI and manufacturing scale. It forecasts global humanoid and legged robot shipments rising from about 60k units in 2026 to about 1.75m by 2030, while China shipments rise from about 50k to 900k. China and the wider Asia-Pacific region are expected to remain central because of robotics research, AI development and manufacturing capacity. Potential use cases include logistics, manufacturing, healthcare and consumer applications. The report nevertheless sees a more demanding transition from technical demonstrations to mainstream deployment. The key test is no longer whether robots can perform staged tasks, but whether they can work safely, reliably and economically in real settings. JPMorgan expects the next 6–12 months to be challenging as fast product cycles, new launches and aggressive pricing can support volumes while constraining profitability. Technical bottlenecks, regulatory scrutiny, uncertainty around revenue quality and evolving business models make mass adoption non-linear. The report believes companies must demonstrate repeatable enterprise demand, margin resilience and scalable platform value. This changes the preferred positioning from hardware-led OEMs toward upstream component suppliers with scarcity and multi-OEM exposure. JPMorgan sees Leader Drive and Orbbec as “shovel sellers” that can benefit from supply-side ecosystem expansion, rising content per robot and sales to multiple OEMs. Its preference order is Leader Drive and Orbbec, both Overweight, ahead of Inovance and Yiheda at Neutral, UBTech at Neutral, and Estun and Unitree at Underweight. The central valuation argument is that platform economics, recurring revenue potential, ecosystem integration and defensible moats should increasingly matter more than simple revenue multiples or headline shipments. For UBTech, JPMorgan downgrades the stock to Neutral and lowers its Dec-27 target price to HK$74 from HK$118, using 5x FY27E P/S versus 8x previously. The report cites reduced expectations, a lack of near-term catalysts, reduced valuation support following share sales by major pre-IPO investors including Tencent, a crowded IPO pipeline and higher regulatory/compliance uncertainty. UBTech has more than 10 customers in trial runs or with confirmed orders, including BYD, Dongfeng Liuzhou Motor, Zeekr, Seres, Foxconn and BAIC, and its new ultra-bionic humanoid robot could support shipments if consumer and retail adoption accelerates. Still, JPMorgan considers its scarcity premium less defensible than those of component leaders and awaits clearer commercial traction and margin resilience. For Orbbec, JPMorgan remains Overweight but reduces the Dec-27 target price to Rmb110 from Rmb140 and lowers its target multiple to 18x FY27E P/S from 23x. Cognex’s acquisition of RealSense for about US$500m, or about 6x FY26E P/S, provides a public valuation reference and raises the growth and margin proof burden, even though JPMorgan does not consider RealSense a true comparable at this stage. Orbbec has more than 70% share of China’s service and humanoid-robot vision market and sales about 2.4x RealSense’s. JPMorgan views its installed-base loop—more customer touchpoints, data, use cases and ecosystem relevance—as a differentiator, and keeps FY27/28 earnings estimates about 20%/40% above Bloomberg consensus. Leader Drive remains JPMorgan’s top upstream component pick. The firm retains an Overweight rating and a Dec-27 Rmb358 target price, despite cutting it from Rmb481, implying about 30% potential upside and 39x/28x FY27E/28E P/S. JPMorgan raises FY27/28 revenue and earnings forecasts by about 20%/15%, leaving estimates about 25%/35% above consensus. Its thesis rests on the company’s harmonic-reducer moat, engineering depth, supply-chain position and ability to serve multiple OEMs as content per robot rises. Laifual Drive is a material competitive challenge, with harmonic-reducer pricing about 40% below Leader Drive’s, but JPMorgan believes Leader Drive’s scale, customer relationships and engineering expertise support resilience. Valuation multiples across physical-AI and humanoid names range from below 1x to above 45x FY27E P/S, reflecting legacy-business dilution, direct robot exposure, optionality and business-model scalability. JPMorgan uses a P/S framework for early-stage companies and incorporates scarcity and platform positioning. For Leader Drive, it also uses DCF, assuming a 5% terminal growth rate and 7.7% WACC, derived from an 11.1% cost of equity, 4.3% after-tax cost of debt and a target structure of 50% debt to total capital.

Analysis framework

JPMorgan begins with sector shipment growth and deployment conditions, then assesses which parts of the value chain can convert growth into durable economics. It compares OEM and component-company exposure, competitive risks, valuation multiples, estimate revisions and ecosystem positioning. Company valuation relies mainly on forward P/S multiples, supplemented by DCF for Leader Drive.

Methodology notes

• Industry AnalysisUpstream-Midstream-Downstream Transmission

  Upstream component suppliers versus downstream robot OEMs

  The report argues that harmonic-reducer and 3D-vision suppliers can benefit from expanding robot production across multiple OEM customers, while OEMs face more direct competition, pricing and deployment risks.

• Valuation methodsPS valuation

  Forward price-to-sales valuation

  JPMorgan uses FY27E P/S multiples to set or assess target prices, reflecting early-stage revenue growth, scarcity, optionality and platform potential.

• Valuation methodsDCF (Discounted Cash Flow)

  Leader Drive DCF valuation

  The report supports Leader Drive’s target price with a discounted-cash-flow model using a 5% terminal growth rate and 7.7% WACC.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• UBTECH Robotics - H (9880.HK)

  Humanoid robot OEM facing a more selective market and reduced near-term valuation support.

  Strengths

  Visible China humanoid-robot name, full-stack technology platform, over 10 clients in trials or with confirmed orders, and potential consumer/retail upside from its ultra-bionic robot.

  Weaknesses

  Less defensible scarcity value than component leaders, limited large-scale deployment visibility and lack of near-term catalysts.

  Comparison

  Trades above Estun on P/S but at about a 90% P/E discount to Unitree; JPMorgan prefers Leader Drive and Orbbec.

  Risks

  Order conversion, industry adoption, competition, regulatory scrutiny, margin pressure and dilution from new listings.

• Orbbec - A (688322.SS)

  Preferred upstream 3D-vision and perception supplier in the physical-AI ecosystem.

  Strengths

  More than 70% China share in service and humanoid robot vision hardware, sales about 2.4x RealSense, supply-chain control, customization and ecosystem integration.

  Weaknesses

  Higher burden to demonstrate growth, gross-margin improvement and defensible software value after the Cognex-RealSense transaction.

  Comparison

  JPMorgan does not regard RealSense as a true comparable, but its acquisition creates a public valuation reference.

  Risks

  Slower market growth, rising competition and migration toward lower-ASP vision hardware standards.

• Leader Harmonious Drive System Co. (688017.SS)

  JPMorgan’s top upstream component pick and harmonic-reducer supplier.

  Strengths

  Harmonic-reducer moat, engineering depth, customer relationships, multi-OEM sales potential and rising content per robot.

  Weaknesses

  Scarcity is challenged by new entrants, particularly Laifual Drive.

  Comparison

  Laifual Drive’s harmonic-reducer pricing is about 40% below Leader Drive’s.

  Risks

  Weaker quarterly sales, pricing competition, margin compression and slower humanoid-robot adoption.

Key data

• Global humanoid and legged robot shipmentsc.60k units in 2026 to c.1.75m units in 2030JPMorgan’s sector growth forecast.
• China humanoid and legged robot shipmentsc.50k units in 2026 to 900k units in 2030China is expected to be the largest and fastest-growing region.
• UBTech Dec-27 target priceHK$74Reduced from HK$118; based on 5x FY27E P/S versus 8x previously.
• Orbbec Dec-27 target priceRmb110Reduced from Rmb140; 28% potential upside and 18x FY27E P/S.
• Leader Drive Dec-27 target priceRmb358Reduced from Rmb481; about 30% potential upside and 39x/28x FY27E/28E P/S.
• Cognex acquisition of RealSensec.US$500m; c.6x FY26E P/SA valuation reference that raises concerns about potential valuation convergence for Orbbec.

Impact & implications

JPMorgan expects capital-market attention to shift from headline robot shipments toward evidence of reliable deployment, repeatable demand, margins, recurring platform value and ecosystem control. It believes upstream suppliers with scarce components and broad OEM exposure are better positioned than hardware-led OEMs during this transition.

Risks

• Humanoid-robot adoption may develop more slowly than expected because deployment, reliability and economic-value hurdles remain.
• Intensifying competition, rapid product cycles and aggressive pricing could pressure margins and market share.
• Regulatory scrutiny, including revenue-quality and compliance concerns, may constrain growth for OEMs.
• New component suppliers and valuation references could reduce scarcity premiums and trigger valuation convergence.
• For UBTech, trial-to-order conversion and sales growth may disappoint; for Orbbec, lower-ASP vision standards are a risk; for Leader Drive, lower-priced competitors could pressure pricing.

What to watch

• Evidence of repeatable enterprise demand, reliable deployment and margin resilience across humanoid-robot companies.
• Progress converting UBTech customer trials and confirmed orders into scaled commercial deployment.
• The effect of Cognex’s RealSense acquisition on Orbbec’s valuation, growth expectations and perception-market competition.
• Whether Orbbec sustains market share, supply-chain control, software value and ecosystem integration.
• Whether Leader Drive can defend pricing and margins against Laifual Drive while scaling sales across OEMs.
• Changes in regulatory scrutiny, policy support and the pace of new robotics IPOs.